Axon Surges on Earnings, But Still Down 50% From Highs

Axon Enterprise's stock jumped nearly 11% following its Q1 2026 earnings release, marking a significant win after a prolonged downturn. The company reported revenue of $807.3 million, a 34% year-over-year increase that handily beat estimates of $778.9 million. Adjusted earnings per share also edged out expectations, coming in at $1.61.

Despite this positive reaction, the stock remains in a deep hole, trading at less than 50% of its 52-week high from August 2025. At its peak, Axon was valued at a forward P/E ratio near 130x, a valuation that demanded flawless execution.

The company's gross margin contracted by 150 basis points to 59.1%, which management attributed to global tariffs. However, Axon raised its full-year revenue growth guidance to a midpoint of 31%, up from prior guidance of 29%, and maintained its EBITDA margin outlook.

Critically, the earnings report highlighted explosive growth in key strategic areas. Bookings for its premium 'AI Era' plan soared 140% year-over-year, and counter-drone revenue skyrocketed 300%. These results directly counter the narrative that AI is a threat to Axon's software business.

This report matters because it demonstrates the core strength of Axon's 'flywheel' business model is intact and accelerating. The company is not just selling hardware; it's locking in multi-year, high-margin software and service contracts, with AI now becoming a central part of law enforcement purchasing decisions.

The massive growth in AI Era plan bookings (140% YoY) shows that AI is a powerful revenue driver for Axon, not a competitive threat. Agencies are buying the full package, which starts with essential hardware like Tasers and body cameras and leads to recurring software revenue.

This hardware-first model provides a durable moat. Competitors can't easily replicate Axon's AI software offerings like Draft One without first displacing its entrenched hardware in the field. The spike in drone revenue further diversifies the business into a high-growth defense segment.

Financially, the raised guidance on strong bookings growth (44% YoY) provides high visibility into future revenue, making the current steep stock discount harder to justify. The market's tendency to lump Axon with pure-software stocks appears to be a persistent misclassification, creating a potential valuation gap.

Analyst price targets, even those lowered post-earnings, still imply 50% to 75% upside, suggesting professional investors see a fundamental disconnect between the company's performance and its stock price.